Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Thursday, April 9, 2026.
Oramed Pharmaceuticals Inc. (NASDAQ:ORMP)
Long-Term Uptrend (+90) - ORMP is in a strong uptrend that is likely to continue. While ORMP is showing intraday weakness, it remains in the confines of a bullish trend. Traders should use caution and utilize a stop order.
Is it time to buy, sell, or avoid ORMP?
MarketClub looks at technical strength and momentum to determine if the timing is right for ORMP.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for ORMP
The long-term trend has been UP since Sep 11th, 2025 at 2.4350
The intermediate-term trend has been UP since Feb 25th, 2026 at 3.5227
The short-term trend has been UP since Apr 6th, 2026 at 3.4699
Smart Scan Analysis for ORMP
Based on our trend formula, ORMP is rated as a +90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 3.5100 | 3.5350 | 3.4347 | 3.4870 | -0.0330 |
| Prev. Close | Volume | Bid | Ask | Time |
| 3.4800 | 78921 | 2026-04-08 15:59:52 |
| Year High | 9.24 | Year High Date | 2018-01-05 |
| Year Low | 3.91 | Year Low Date | 2018-11-13 |
| 52wk High | 3.76 | 52wk High Date | 2026-02-25 |
| 52wk Low | 1.82 | 52wk Low Date | 2025-04-09 |
| Year End Close | 3.96 | Average Volume | 102,724 |
| Shares Outstanding | 40,446 | % Institutional | 10.1 |
| Assets | 230,864,000M | Liabilities | 31,120,000M |
| P/E Ratio | 2.32 | Beta | -0.15000000 |
| Volatility | 42.29 |